The Cancer Letter

Inside information on cancer research and drug development

Capitol Hill

Senate HELP Committee votes 15-6 to advance Bertagnolli’s confirmation as NIH director

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

Monica Bertagnolli testifies during her Senate Health, Education, Labor and Pensions Committee confirmation hearing to be the next NIH Director, Oct. 18, 2023 Photo credit: Kevin Dietsch/Getty Images

A Senate Committee Oct. 25 voted 15-6 to advance the confirmation of Monica Bertagnolli to the role of NIH director. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
Alexandria Carolan
Alexandria Carolan
Reporter
Table of Contents

YOU MAY BE INTERESTED IN

Climate change exacerbates cancer disparities
Amid disasters, oncologists see urgent need for methodologies, metrics for gauging the problem

Ivan Borrello, medical director of the Myeloma, Bone Marrow Transplant and Cell Therapies Program at Tampa General Hospital’s Cancer Institute, watched as flood waters from Hurricane Helene heaved against a contraption called the AquaFence, which is, as the name suggests, a water-impermeable barrier made of marine-grade laminate and various metals that can withstand storm surges of up to 15 feet above sea level. 
By Claire Marie Porter
Byline
Alexandria Carolan
Alexandria Carolan
Reporter
Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account